AMAG Pharmaceuticals (AMAG)

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q1 2018 Results - Earnings Call Transcript
May 3, 2018 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q4 2017 Results - Earnings Call Transcript
Feb. 27, 2018 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q3 2017 Results - Earnings Call Transcript
Nov. 5, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2017 Results - Earnings Call Transcript
Aug. 3, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2017 Results - Earnings Call Transcript
May 2, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2016 Results - Earnings Call Transcript
Feb. 14, 2017 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q3 2016 Results - Earnings Call Transcript
Nov. 4, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2016 Results - Earnings Call Transcript
Aug. 10, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden Presents at Deutsche Bank 41st Annual Health Care C
May 5, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2016 Results - Earnings Call Transcript
May 3, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q4 2015 Results - Earnings Call Webcast
Feb. 17, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2015 Results - Earnings Call Transcript
Feb. 17, 2016 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William HeidenonQ3 2015 Results - Earnings Call Transcript
Nov. 3, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q3 2015 Results - Earnings Call Webcast
Nov. 3, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q2 2015 Results - Earnings Call Transcript
July 23, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q1 2015 Results - Earnings Call Transcript
May 5, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q1 2015 Results - Earnings Call Webcast
May 5, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q4 2014 Results - Earnings Call Webcast
Feb. 9, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q4 2014 Results - Earnings Call Transcript
Feb. 9, 2015 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO William Heiden on Q3 2014 Results - Earnings Call Transcript
Nov. 2, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals (AMAG) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' (AMAG) CEO Bill Heiden on Q2 2014 Results - Earnings Call Transcript
July 29, 2014 | Price: Free! | Source: Seeking Alpha

Q2 2014 Amag Pharmaceuticals In Earnings Conference Call (Webcast)
July 29, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses Q1 2014 Results - Earnings Call Transcript
April 26, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 6, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Host's host Corporate Conference Call To Provide A Regulatory Update (Tra
Jan. 22, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript)
Jan. 15, 2014 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2013 Earnings Conference Call Transcript
Oct. 23, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 23, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses PDUFA Date Extension Conference Call (Transcript)
Oct. 17, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Conferenca Call to discuss the PDUFA date extension Transcript
Oct. 17, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals Management Presents at Morgan Stanley Global Healthcare Conference (Transcript
Sept. 9, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 2, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q2 2013 Earnings Conference Call Transcript
Aug. 1, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Results - Earnings Call Transcript
April 23, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q1 2013 Earnings Conference Call Transcript
April 23, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Presents at Positive Preliminary Results from IDA-303 Study Conference (T
March 15, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc Conference Call to Discuss Positive Preliminary Results from IDA-303 Study
March 15, 2013 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at Cowen Health Care Conference Transcript
March 4, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at JPMorgan Global Healthcare Conference (Q and A Session) Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. at JPMorgan Global Healthcare Conference Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals' COO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Tran
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Discusses Q3 Results - Earnings Call Transcript
Nov. 1, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2012 Earnings Conference Call Transcript
Nov. 1, 2012 | Price: $106.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Presents at Morgan Stanley Healthcare Conference (Transcript)
Sept. 10, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. at Morgan Stanley Healthcare Conference Transcript
Sept. 10, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc.(AMAG) Q2 2012 Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc. Q2 2012 Earnings Conference Call Transcript
July 26, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals' CEO Presents IDA-301 Data (Transcript)
July 20, 2012 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals IDA-301 Data Conference Call Transcript
July 18, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc. at Goldman Sachs Healthcare Conference Transcript
June 6, 2012 | Price: $54.00 | Source: Thomson

AMAG Pharmaceuticals, Inc.(AMAG) Q1 2012 Earnings Call Transcript
May 1, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q4 2011 Earnings Call Transcript
March 5, 2012 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q3 2011 Earnings Call Transcript
Nov. 4, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q2 2011 Earnings Call Transcript
July 26, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals, Inc.(AMAG) Q1 2011 Earnings Call Transcript
May 3, 2011 | Price: Free! | Source: Morningstar

AMAG Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 29, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
July 29, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q1 2010 Earnings Call Transcript
April 28, 2010 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
April 30, 2009 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript
Feb. 27, 2009 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Nov. 3, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
July 29, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
June 23, 2008 | Price: Free! | Source: Seeking Alpha

AMAG Pharmaceuticals Inc. Q4 2007 Earnings Call Transcript
Feb. 21, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Automatic shelf registration statement of securities of well-known seasoned issuers - June 13, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals director just picked up 3,578 shares - June 8, 2018

AMAG Pharmaceuticals's President & CEO just disposed of 20,000 shares - June 5, 2018

Amag Pharmaceuticals Announces First Quarter 2018 Financial Results AND RAISES FULL YEAR FINANCIAL GUIDANCE - May 3, 2018

EVP of AMAG Pharmaceuticals just declared 0 ownership of the company. - May 2, 2018

EVP of AMAG Pharmaceuticals just picked up 28,418 shares - May 2, 2018

AMAG Pharmaceuticals releases salary data. CEO sees compensation rise 43% - April 25, 2018

Steven Boyd just provided an update on share ownership of AMAG Pharmaceuticals - April 5, 2018

On March - March 23, 2018

EVP of AMAG Pharmaceuticals just picked up 19,350 shares - March 6, 2018

AMAG Pharmaceuticals's President & CEO just picked up 80,454 shares - March 6, 2018

EVP of AMAG Pharmaceuticals just picked up 23,300 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Human Resources Officer just picked up 14,451 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Financial Officer just picked up 19,146 shares - March 6, 2018

AMAG Pharmaceuticals's Chief Commercial Officer just picked up 17,807 shares - March 6, 2018

AMAG Pharmaceuticals Just Filed Its Annual Report: The following is a s... - March 1, 2018

AMAG: Financial Results And Company Update GAAP Revenue Increased - Feb. 27, 2018

Amag Pharmaceuticals Announces Fda Approval Of - Feb. 15, 2018

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2018

STATE STREET CORPORATION just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2018

The Vanguard Group just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 8, 2018

Janus Capital Management LLC EIN just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 6, 2018

Amag Pharmaceuticals Announces Fda Approval Of Supplemental New Drug Application (Snda) For Feraheme - Feb. 5, 2018

Confidential treatment order - Feb. 1, 2018

BlackRock, Inc. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 23, 2018

Amag Pharmaceuticals Announces Preliminary 2017 Financial Results - Jan. 8, 2018

AMAG Pharmaceuticals's Chief Human Resources Officer just declared owning 42,155 shares of AMAG Pharmaceuticals - Dec. 5, 2017

Departure of Directors or Certain - Nov. 30, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: The following is a s... - Nov. 6, 2017

Amag Pharmaceuticals Announces Third Quarter 2017 Financial Results AND BUSINESS HIGHLIGHTS Intrarosa - Nov. 2, 2017

Departure of Directors or Certain - Sept. 13, 2017

SVP of AMAG Pharmaceuticals just disposed of 1,250 shares - Aug. 30, 2017

SVP of AMAG Pharmaceuticals just disposed of 1,633 shares - Aug. 28, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: BASIC AND DILUTED NE... - Aug. 4, 2017

Amag Pharmaceuticals Announces Second Quarter 2017 Financial Results AND PROVIDES CORPORATE UPDATE - Aug. 3, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - July 31, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 4,938 shares - July 14, 2017

Statement of acquisition of beneficial ownership by individuals - July 10, 2017

Securities to be offered to employees in employee benefit plans - June 23, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 3,503 shares - June 5, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - May 25, 2017

Current report, items 5.02, 5.07, 7.01, and 9.01 - May 24, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

AMAG Pharmaceuticals director just picked up 4,545 shares - May 22, 2017

Stephen DuBois Not applicable just provided an update on share ownership of AMAG Pharmaceuticals - May 15, 2017

Entry into a Material Definitive - May 15, 2017

AMAG Pharmaceuticals's Chief Commercial Officer just disposed of 3,483 shares - May 10, 2017

AMAG Pharmaceuticals's Chief Financial Officer just disposed of 2,177 shares - May 10, 2017

SVP of AMAG Pharmaceuticals just disposed of 980 shares - May 10, 2017

AMAG Pharmaceuticals's President & CEO just disposed of 19,085 shares - May 10, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 8, 2017

AMAG Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 8, 2017

Amag Pharmaceuticals Announces Proposed Offering Of $250 Million Of Convertible Senior Notes Due 2022 - May 8, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 5, 2017

Filing [Trust Indenture Act] - May 3, 2017

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 3, 2017

For purposes of the registration statement on - May 3, 2017

AMAG Pharmaceuticals just filed a prospectus, suggesting it plans to soon issue some securities - May 3, 2017

AMAG Pharmaceuticals Just Filed Its Quarterly Report: BASIC AND DILUTED NE... - May 3, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 1,891 shares - May 2, 2017

Amag Pharmaceuticals Announces First Quarter 2017 Financial Results AND PROVIDES CORPORATE UPDATE - May 2, 2017

AMAG Pharmaceuticals releases salary data. CEO sees compensation fall -19% - April 20, 2017

Other preliminary proxy statements - April 10, 2017

Registration of securities [Section 12(b)] - April 10, 2017

Material Modification to Rights of Security - April 10, 2017

Amag Pharmaceuticals Announces Closing Of Exclusive Licensing Agreement With Endoceutics For U.S. Rights To INTRAROSA  (PRASTERONE) - April 5, 2017

Confidential treatment order - March 20, 2017

Amag Announces Management Changes And New Commercial Appointments - March 6, 2017

AMAG Pharmaceuticals's CEO just picked up 85,000 shares - Feb. 27, 2017

SVP of AMAG Pharmaceuticals just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's Chief Commercial Officer just picked up 20,000 shares - Feb. 27, 2017

SVP Clinical & Regulatory of AMAG Pharmaceuticals just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's President & COO just picked up 24,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals's Chief Financial Officer just picked up 15,000 shares - Feb. 27, 2017

AMAG Pharmaceuticals Just Filed Its Annual Report: Basic and Diluted Ne... - Feb. 21, 2017

Amag Reports Fourth Quarter And Full Year Financial Results - Feb. 14, 2017

Steven A. Cohen just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 14, 2017

Janus Capital Management LLC EIN just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 13, 2017

STATE STREET CORPORATION just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 10, 2017

Westfield Capital Management Company, LP just issued a filing suggesting it has sold all of its AMAG Pharmaceuticals - Feb. 10, 2017

Phillip Gross just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 9, 2017

The Vanguard Group just provided an update on share ownership of AMAG Pharmaceuticals - Feb. 9, 2017

Amag Pharmaceuticals Announces Closing Of Exclusive Licensing Agreement For North American Rights To Rekynda  (BREMELANOTIDE) - Feb. 3, 2017

Palo Alto Healthcare Master Fund II, L.P. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 12, 2017

BlackRock, Inc. just provided an update on share ownership of AMAG Pharmaceuticals - Jan. 12, 2017

Amag Pharmaceuticals Provides Financial And Business Update - Jan. 9, 2017

Amag Pharmaceuticals Announces Appointment Of Brian Kelley To Board Of Directors - Dec. 22, 2016

AMAG Pharmaceuticals director just declared 0 ownership of the company. - Dec. 22, 2016

AMAG Pharmaceuticals director just picked up 1,026 shares - Dec. 22, 2016

Confidential treatment order - Nov. 14, 2016

AMAG: Financial Results And Provides Corporate Update - Nov. 3, 2016

SVP Clinical & Regulatory of AMAG Pharmaceuticals just disposed of 4,938 shares - Oct. 20, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. STEELHEAD PARTNERS LLC 39,700,000 2.9 March 31, 2018
2. CNH PARTNERS LLC 33,575,000 0.4 Dec. 31, 2017
3. CAMDEN ASSET MANAGEMENT L P /CA 32,375,000 0.9 Sept. 30, 2017
4. Citadel Advisors LLC 32,050,900 N/A Sept. 30, 2017
5. TENOR CAPITAL MANAGEMENT Co., L.P. 22,600,000 1.5 Dec. 31, 2017
6. DEERFIELD MANAGEMENT CO 16,250,000 0.7 Sept. 30, 2017
7. DEUTSCHE BANK AG\ 14,652,789 N/A March 31, 2018
8. DEUTSCHE BANK AG\ 13,263,160 N/A Dec. 31, 2017
9. Citadel Advisors LLC 12,319,942 N/A March 31, 2018
10. WOLVERINE ASSET MANAGEMENT LLC 12,192,900 0.1 Sept. 30, 2017
11. UBS Group AG 11,672,779 N/A Dec. 31, 2017
12. D. E. Shaw & Co., Inc. 11,467,715 N/A Dec. 31, 2017
13. NOMURA HOLDINGS INC 10,550,000 N/A March 31, 2018
14. Calamos Advisors LLC 10,000,000 0.1 March 31, 2018
15. UBS Group AG 9,564,390 N/A March 31, 2018
16. UBS Group AG 9,564,390 N/A March 31, 2018
17. JPMORGAN CHASE & CO 9,081,381 N/A Dec. 31, 2017
18. Telemetry Investments, L.L.C. 8,250,000 2.3 Dec. 31, 2017
19. Opera Trading Capital 7,500,000 0.6 March 31, 2018
20. Birch Grove Capital LP 7,424,000 3.5 March 31, 2018
21. Verition Fund Management LLC 7,398,000 0.5 March 31, 2018
22. JPMORGAN CHASE & CO 7,395,166 N/A Sept. 30, 2017
23. BlackRock Inc. 6,388,539 N/A Dec. 31, 2017
24. BlackRock Inc. 5,650,354 N/A June 30, 2017
25. Bruce & Co., Inc. 5,500,000 1.0 March 31, 2018
26. OAKTREE CAPITAL MANAGEMENT LP 5,335,000 0.1 March 31, 2018
27. Context Capital Management, LLC 5,250,000 2.1 Dec. 31, 2017
28. PT ASSET MANAGEMENT, LLC 5,000,000 2.3 Dec. 31, 2017
29. PALISADE CAPITAL MANAGEMENT LLC/NJ 5,000,000 0.2 March 31, 2018
30. BlackRock Inc. 4,995,412 N/A March 31, 2017

AMAG Pharmaceuticals (AMAG)

140
 


Feedback